Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

MediLink Therapeutics (Suzhou) Co., Ltd.

2 clinical trials · 2 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by MediLink Therapeutics (Suzhou) Co., Ltd.

RECRUITINGPhase 1 / Phase 2NCT07169994

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

This is a multicenter, open-label, phase Ib/II study of YL202 in combination with other anti-tumor therapies to Evaluate the Safety, Tolerability, and Efficacy in Patients with...

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.Enrolling: 41420 locations
Advanced Solid TumorsBreast CancerNon Small Cell Lung Cancer
RECRUITINGPhase 3NCT06629597

A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma

This study was designed to compare the efficacy and safety of YL201 with Investigator's choice of chemotherapy in subjects with recurrent or metastatic nasopharyngeal carcinoma...

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.Enrolling: 4001 location
Nasopharyngeal Carcinoma